Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001204631 | SCV001375844 | uncertain significance | Hereditary nonpolyposis colorectal neoplasms | 2019-09-14 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with MSH6-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with aspartic acid at codon 1350 of the MSH6 protein (p.Val1350Asp). The valine residue is weakly conserved and there is a large physicochemical difference between valine and aspartic acid. |
| Baylor Genetics | RCV004570432 | SCV005054907 | uncertain significance | Endometrial carcinoma | 2024-02-20 | criteria provided, single submitter | clinical testing |